Company Filing History:
Years Active: 2013-2015
Title: Yuki Takenaka: Innovator in Cellular Therapeutics
Introduction
Yuki Takenaka is a prominent inventor based in Tsu, Japan. She has made significant contributions to the field of cellular therapeutics, holding 2 patents that focus on innovative methods for expressing exogenous GITR ligands.
Latest Patents
Her latest patents include a cell capable of expressing an exogenous GITR ligand. The disclosures detail a cell that can express an exogenous GITRL or its derivatives, along with methods for producing such cells. Additionally, these patents describe therapeutic or prophylactic agents that comprise the cell as an active ingredient. They also cover the use of the cell in manufacturing therapeutic agents and methods for administering the cell to subjects. Furthermore, a viral vector carrying a gene encoding a GITRL or its derivatives is included, along with therapeutic agents comprising the viral vector as an active ingredient and methods for administering it to subjects.
Career Highlights
Yuki Takenaka has worked with notable institutions such as Mie University and Takara Bio Inc. Her work in these organizations has allowed her to advance her research and contribute to the scientific community.
Collaborations
She has collaborated with esteemed colleagues, including Hiroshi Shiku and Hiroaki Ikeda, which has further enriched her research endeavors.
Conclusion
Yuki Takenaka's innovative work in cellular therapeutics and her contributions to the field through her patents highlight her role as a significant inventor. Her research continues to pave the way for advancements in therapeutic applications.